Drug Trial Radar · NCT07063576
Effect of Baclofen in Management of Patients With Gastroesophageal Reflux Disease Symptoms
Last checked: Nov 20, 2026Latest source record: Aug 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Aug 1, 2025
Primary completion
Jul 2026
Study completion Jul 2026
Sponsor
- Lead sponsor
- Adnan Imtiaj RahulAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 14, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to assess the effect of using baclofen along with conventional treatment in improving GERD symptoms. It will also assess the safety of drug baclofen by recording the patient reported adverse events. The main questions it aims to answer are : Does drug baclofen along with conventional treatment has any effect on patients with GERD symptoms? What medical problems do participants have when taking drug baclofen? Researcher will compare drug baclofen along with conventional treatment to a control group taking placebo along with conventional treatment. Participants will: Take drug baclofen 10 milligrams or placebo three times daily along with conventional treatment for 4 weeks. They will visit the hospital after 4 weeks. Their symptoms will be assessed via validated GERD Q questionnaire at baseline and after 4 weeks. Additionally, patient reported adverse events will be documented.
Conditions
- GERD - PPI Non-responders
Interventions
Baclofen 10mgDrug
Tablet baclofen 10mg three times daily along with conventional treatment
PlaceboDrug
Tablet placebo three times daily along with conventional treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- Improvement of GERD symptomsTime frame: At baseline before randomization and at week 4
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Dhaka Medical College
Dhaka, Bangladesh · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.